Arbutus announces new data on ab-729 and ab-836 programs with presentation of five abstracts at the easl international liver congress™ 2021 - all selected for best of ilc™

Ab-729, dosed at 60 mg every 8 weeks, achieved a mean hbsag decline of -1.87 log10 iu/ml at week 44, comparable to 60 mg dosed every 4 weeks

ABUS Ratings Summary

ABUS Quant Ranking